In addition, it has been shown that high levels of KRT17 expression in cervical cancer are associated with poor prognosis and cancer cell differentiation, and that KRT17 could be used as a prognostic biomarker [26–28]. This evidence concerns the gene KRT17 and cervical carcinoma.